Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Jackisch

Showing results (11-20 of 231) with videos related to

Pageof 24
Sort By:
Breast Care (Basel, Switzerland)|December 21, 2023
Endocrine Therapy: From Ovarian Ablation to Individualized Therapy and Signal InhibitionChristian Jackisch, Athanasios Argyriadis
Zeitschrift Fur Geburtshilfe Und Neonatologie|May 12, 2020
[Using Cervical Pessary to Prevent Premature Birth - a Clinical Analysis]Anna Hentrich, Susanne Marek, Christian Jackisch
Breast Care (Basel, Switzerland)|December 17, 2010
Antibodies and Tyrosine Kinase Inhibitors in Breast Cancer TherapiesJ Barth, Christian Jackisch, Michael Untch
Breast Care (Basel, Switzerland)|September 9, 2010
Development of Targeted Therapies in ErbB2-Positive Breast CancerChristian Jackisch, Josef Rüschoff, Axel Ullrich
Breast (Edinburgh, Scotland)|February 26, 2017
Evolving landscape of human epidermal growth factor receptor 2-positive breast cancer treatment and the future of biosimilarsChristian Jackisch, Philip Lammers, Ira Jacobs
Breast Care (Basel, Switzerland)|September 18, 2010
Future Roles of Lapatinib in ErbB2-Positive Breast Cancer: Adjuvant and Neoadjuvant TrialsSerban-Dan Costa, Christian Jackisch, Christoph Thomssen
Targeted Oncology|March 12, 2021
An Overview of PARP Inhibitors for the Treatment of Breast CancerLaura Cortesi, Hope S Rugo, Christian Jackisch
Breast Care (Basel, Switzerland)|November 19, 2014
Adverse event management of oral mucositis in patients with breast cancerSabine Seiler, Jens Kosse, Sibylle Loibl, et al.
NPJ Breast Cancer|May 31, 2023
Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancerMark Pegram, Christian Jackisch, Stephen R D Johnston
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 2002
Comparative examination of complaints of patients with breast-cancer with and without silicone implantsImke Berner, Markus Gaubitz, Christian Jackisch, et al.
Pageof 24

Showing results (11-20 of 231) with videos related to

Sort By:
Pageof 24
Breast Care (Basel, Switzerland)|December 21, 2023
Endocrine Therapy: From Ovarian Ablation to Individualized Therapy and Signal InhibitionChristian Jackisch, Athanasios Argyriadis
Zeitschrift Fur Geburtshilfe Und Neonatologie|May 12, 2020
[Using Cervical Pessary to Prevent Premature Birth - a Clinical Analysis]Anna Hentrich, Susanne Marek, Christian Jackisch
Breast Care (Basel, Switzerland)|December 17, 2010
Antibodies and Tyrosine Kinase Inhibitors in Breast Cancer TherapiesJ Barth, Christian Jackisch, Michael Untch
Breast Care (Basel, Switzerland)|September 9, 2010
Development of Targeted Therapies in ErbB2-Positive Breast CancerChristian Jackisch, Josef Rüschoff, Axel Ullrich
Breast (Edinburgh, Scotland)|February 26, 2017
Evolving landscape of human epidermal growth factor receptor 2-positive breast cancer treatment and the future of biosimilarsChristian Jackisch, Philip Lammers, Ira Jacobs
Breast Care (Basel, Switzerland)|September 18, 2010
Future Roles of Lapatinib in ErbB2-Positive Breast Cancer: Adjuvant and Neoadjuvant TrialsSerban-Dan Costa, Christian Jackisch, Christoph Thomssen
Targeted Oncology|March 12, 2021
An Overview of PARP Inhibitors for the Treatment of Breast CancerLaura Cortesi, Hope S Rugo, Christian Jackisch
Breast Care (Basel, Switzerland)|November 19, 2014
Adverse event management of oral mucositis in patients with breast cancerSabine Seiler, Jens Kosse, Sibylle Loibl, et al.
NPJ Breast Cancer|May 31, 2023
Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancerMark Pegram, Christian Jackisch, Stephen R D Johnston
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 2002
Comparative examination of complaints of patients with breast-cancer with and without silicone implantsImke Berner, Markus Gaubitz, Christian Jackisch, et al.
Pageof 24